Premarket analyst action - healthcare

|By:, SA News Editor

Abeona Therapeutics (NASDAQ:ABEO) initiated with Buy rating and $17 (70% upside) price target at Mizuho Securities.

Sarepta Therapeutics (NASDAQ:SRPT) initiated with Outperform rating and $170 (39% upside) price target at Bernstein.

Elanco Animal Health (NYSE:ELAN) initiated with Hold rating at Craig Hallum.

Alder Biopharmaceuticals (NASDAQ:ALDR) downgraded to Neutral with a $15 (12% upside) price target at Mizuho.

Aphria (OTCQB:APHQF) downgraded to Sell with a C$19 (4% downside risk) price target at Veritas.

Allscripts (NASDAQ:MDRX) downgraded to Neutral at Evercore ISI.

Molina Healthcare (NYSE:MOH) downgraded to Hold with a $152 (10% upside) price target at Jefferies. Shares down a fraction premarket.

Immune Design (NASDAQ:IMDZ) downgraded to Market Perform at Leerink Partners following company's announced termination of internal development of CMB305.

Subscribe for full text news in your inbox